The Role of Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

BACKGROUND: The use of circulating tumor DNA (ctDNA) to reflect clinical benefits of advanced non-small cell lung cancer (NSCLC) patients during immune checkpoint inhibitor (ICI) therapy remains controversial. This study aimed to determine the association of pre-treatment and early dynamic changes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haowei, Zhou, Fei, Qiao, Meng, Li, Xuefei, Zhao, Chao, Cheng, Lei, Chen, Xiaoxia, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335591/
https://www.ncbi.nlm.nih.gov/pubmed/34367957
http://dx.doi.org/10.3389/fonc.2021.671874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8335591/
https://www.ncbi.nlm.nih.gov/pubmed/34367957
http://dx.doi.org/10.3389/fonc.2021.671874

Ejemplares similares